Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

ALRT announces new additions to the product pipeline

Jan. 9, 1997

Alendronate reduces occurrence of vertebral fractures in Fracture Intervention Trial

Jan. 9, 1997

Celtrix completes phase I studies of SomatoKine

Jan. 8, 1997

Leptin triggers reproductive function

Jan. 8, 1997

Bimoclomol progresses in trials

Jan. 8, 1997

Lilly synthesizes antiobesity proteins

Jan. 8, 1997

Kissei, Servier expand licensing agreement for antidiabetic drug

Jan. 7, 1997

Amgen, Progenitor sign agreement covering leptin receptor technology

Jan. 7, 1997

Clinical results reported for Vivus' MUSE

Jan. 7, 1997

Procrit cleared for new indication

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...